Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 19, 2026
Jay Olson's Stock Ratings
Oppenheimer Analyst
Jay Olson is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
12.7%
Smart Score
Overall Average Return Percentile
66th
Number of Ratings
26
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/01/2026 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 334.78% | $33 → $38 | Maintains | Outperform | Get Alert | |
| 07/28/2026 | FTH | Buy Now | Faeth Therapeutics | $18.80 | 219.15% | → $60 | Initiates | → Outperform | Get Alert | |
| 07/07/2026 | KYNB | Buy Now | Kyntra Bio | $5.06 | 591.86% | → $35 | Initiates | → Outperform | Get Alert | |
| 06/26/2026 | EPRX | Buy Now | Eupraxia Pharmaceuticals | $7.00 | 142.86% | → $17 | Initiates | → Outperform | Get Alert | |
| 06/22/2026 | DFTX | Buy Now | Definium Therapeutics | $33.00 | 81.82% | $40 → $60 | Maintains | Outperform | Get Alert | |
| 06/02/2026 | PRAX | Buy Now | Praxis Precision Medicine | $260.17 | 149.84% | $750 → $650 | Maintains | Outperform | Get Alert | |
| 05/28/2026 | ANL | Buy Now | Adlai Nortye | $10.58 | 202.46% | → $32 | Initiates | → Outperform | Get Alert | |
| 04/27/2026 | TERN | Buy Now | Terns Pharmaceuticals | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/21/2026 | PASG | Buy Now | Passage Bio | $3.53 | 324.93% | $30 → $15 | Maintains | Outperform | Get Alert | |
| 03/31/2026 | PASG | Buy Now | Passage Bio | $3.53 | 749.86% | → $30 | Initiates | → Outperform | Get Alert | |
| 03/10/2026 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | 17.16% | $540 → $600 | Maintains | Outperform | Get Alert | |
| 02/25/2026 | BIOA | Buy Now | Bioage Labs | $4.90 | 1124.49% | → $60 | Initiates | → Outperform | Get Alert | |
| 02/13/2026 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | 5.44% | → $540 | Upgrade | Perform → Outperform | Get Alert | |
| 01/22/2026 | CHRS | Buy Now | Coherus Oncology | $0.97 | 930.93% | → $10 | Initiates | → Outperform | Get Alert | |
| 12/15/2025 | PRAX | Buy Now | Praxis Precision Medicine | $260.17 | 188.27% | $250 → $750 | Maintains | Outperform | Get Alert | |
| 12/09/2025 | TERN | Buy Now | Terns Pharma | — | — | $28 → $58 | Maintains | Outperform | Get Alert | |
| 10/22/2025 | TERN | Buy Now | Terns Pharma | — | — | $20 → $17 | Maintains | Outperform | Get Alert | |
| 10/21/2025 | IBIO | Buy Now | iBio | $0.77 | 550.2% | → $5 | Initiates | → Outperform | Get Alert | |
| 08/04/2025 | MNMD | Buy Now | Mind Medicine | — | — | → $25 | Reinstates | → Outperform | Get Alert | |
| 07/29/2025 | ATAI | Buy Now | ATAI Life Sciences | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 07/08/2025 | PRAX | Buy Now | Praxis Precision Medicine | $260.17 | -55.8% | $97 → $115 | Maintains | Outperform | Get Alert | |
| 06/02/2025 | PRAX | Buy Now | Praxis Precision Medicine | $260.17 | -62.72% | → $97 | Assumes | → Outperform | Get Alert | |
| 05/21/2025 | TVRD | Buy Now | Tvardi Therapeutics | $1.00 | 6400% | → $65 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | SGMT | Buy Now | Sagimet Biosciences | $8.74 | 243.25% | → $30 | Initiates | → Outperform | Get Alert | |
| 12/04/2024 | TERN | Buy Now | Terns Pharma | — | — | $17 → $20 | Maintains | Outperform | Get Alert | |
| 10/31/2024 | TERN | Buy Now | Terns Pharma | — | — | → $17 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved